BUY GLP-1 NASAL PEPTIDE SPRAY (GLUCAGON-LIKE PEPTIDE-1)
This product is meant for research and medical use, and only qualified experts are permitted to use it.
GLP-1 nasal inhibits total glucagon release from pancreatic alpha cells when glucose levels are high. In addition, GLP-1 increases satiety and decreases stomach emptying, and its use is linked to weight loss .
GLP-1 agonists increase glucose-insulin secretion, limit stomach motility, and decrease glucagon levels after meals, resulting in a hypoglycemic effect even after intravenous treatment without hypoglycemia . GLP-1 agonist.
The FDA has approved Glp-1, also known as Liraglutide, for treating weight loss and type 2 diabetes. Semaglutide, a GLP-1 analogue, has a longer duration of action but is only approved for use in type 2 diabetes, although it also stimulates weight loss.
Storage: Lyophilized peptides stored below -18°C.
Research use only. Not for human or animal consumption!
Disclaimer: We do not supply peptides to Any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY FOR medical research by responsible trained and professional individuals. All products listed on this website (https://direct-peptides.com) and provided through Direct Peptides are intended for medical research purposes only. Direct Peptides does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended as a drug, stimulant or for use in any food products.